Integrating Immunotherapy with Locoregional Therapies in HCC: Mechanisms, Biomarkers, and Resistance

Join SIO this fall for a three-part webinar series focused on advancing treatment strategies for hepatocellular carcinoma HCC. Led by an expert, multidisciplinary faculty, the series will delve into optimizing HCC care through sequencing and combination therapy, as well as the integration of immunotherapy with locoregional treatments. Discussions will explore the role of biomarkers and mechanisms of resistance in enhancing therapeutic effectiveness. The series will conclude with an overview of ongoing clinical trials investigating combination approaches to improve patient outcomes in HCC.

Moderator:

Julius Chapiro, MD, PhD | Yale University

Faculty:

Terence Gade, MD, PhD | University of Pennsylvania
Anjana Pillai, MD | University of Chicago
Michael Soulen, MD | University of Pennsylvania

Faculty Panelist: Sarah Manes, MS | Global Liver Institute

Panel Discussion- Julius Chapiro, Terence Gade, Anjana Pillai, Michael Soulen and Sarah Manes